What is VERQUVO?
VERQUVO may help you live longer and stay out of the hospital
VERQUVO is for adults with symptoms of chronic heart failure Long-lasting condition in which the heart is unable to pump enough blood to the body’s tissues to keep organs and tissues healthy. who have recently been hospitalized or received IV medicine, Medicine given through a vein. and have an ejection fraction The amount of blood pumped with each heartbeat. of less than 45 percent.
Did you know?
A heart failure hospitalization may increase your chances of going back to the hospital.*
About 56% of patients hospitalized (or who receive IV medicine) due to increased heart failure symptoms return to the hospital within 30 days.*
*From a study of heart failure patients in the National PINNACLE Registry, where 1,851 patients with ejection fraction (amount of blood pumped with every heartbeat) less than or equal to 45% had increased symptoms of heart failure that required hospitalization or IV medicine.
Learn about the clinical trial
How was VERQUVO studied?
VERQUVO is the first and only FDA-approved medicine studied specifically in people who had a recent heart failure hospitalization or received IV medicine for their heart failure.‡
- Over 5,000 people with heart failure participated
‡Patients had been hospitalized within the previous 6 months or had received IV medicine for heart failure within the previous 3 months.
Is VERQUVO right for me?
Talk to your doctor to see if VERQUVO may be right for you if you have:
- symptoms of chronic heart failure
- been recently hospitalized or the need to receive IV medicines
- an ejection fraction of less than 45 percent
Doctor Discussion Guide
This handy guide has a few questions to ask your doctor and get the conversation started.
VERQUVO is a prescription medicine used in adults who are having symptoms of their chronic (long-lasting) heart failure, who have had a recent hospitalization or the need to receive intravenous (IV) medicines and have an ejection fraction (amount of blood pumped with each heartbeat) of less than 45 percent to reduce the risk of dying and to reduce the need to be hospitalized.
Interested in special offers for VERQUVO?
Looking for support?
Share your story